Daniel Hans

1.6k total citations
18 papers, 1.3k citations indexed

About

Daniel Hans is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Daniel Hans has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 8 papers in Pathology and Forensic Medicine and 7 papers in Oncology. Recurrent topics in Daniel Hans's work include Breast Cancer Treatment Studies (13 papers), Breast Lesions and Carcinomas (8 papers) and Cancer Treatment and Pharmacology (3 papers). Daniel Hans is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), Breast Lesions and Carcinomas (8 papers) and Cancer Treatment and Pharmacology (3 papers). Daniel Hans collaborates with scholars based in France and Switzerland. Daniel Hans's co-authors include H Brandone, Y Aymé, C Bressac, J M Spitalier, R. Amalric, John M. Kurtz, Jocelyne Jacquemier, Jocelyne Jacquemier, Julia Kurtz and Jakob Roth and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Surgery.

In The Last Decade

Daniel Hans

17 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Hans France 9 1.1k 805 515 380 158 18 1.3k
C Bressac France 10 1.2k 1.0× 804 1.0× 534 1.0× 376 1.0× 171 1.1× 17 1.3k
Abram Recht United States 12 976 0.9× 741 0.9× 399 0.8× 276 0.7× 102 0.6× 15 1.1k
Pamela H. Craig United States 8 790 0.7× 684 0.8× 370 0.7× 248 0.7× 63 0.4× 10 965
Malcolm Beinfield United States 11 683 0.6× 505 0.6× 274 0.5× 265 0.7× 92 0.6× 14 765
Howard C. Snider United States 16 1.1k 1.0× 783 1.0× 394 0.8× 567 1.5× 40 0.3× 29 1.4k
Barbara Fowble United States 6 643 0.6× 476 0.6× 233 0.5× 305 0.8× 37 0.2× 10 756
Mark Gittleman United States 18 820 0.7× 437 0.5× 244 0.5× 382 1.0× 50 0.3× 32 1.1k
Linda S. Callans United States 10 763 0.7× 720 0.9× 286 0.6× 388 1.0× 31 0.2× 10 1.1k
Vincenzo Delledonne Italy 10 624 0.5× 601 0.7× 239 0.5× 251 0.7× 55 0.3× 13 920
Gregory M. Senofsky United States 9 792 0.7× 635 0.8× 359 0.7× 351 0.9× 55 0.3× 12 942

Countries citing papers authored by Daniel Hans

Since Specialization
Citations

This map shows the geographic impact of Daniel Hans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Hans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Hans more than expected).

Fields of papers citing papers by Daniel Hans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Hans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Hans. The network helps show where Daniel Hans may publish in the future.

Co-authorship network of co-authors of Daniel Hans

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Hans. A scholar is included among the top collaborators of Daniel Hans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Hans. Daniel Hans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hans, Daniel, et al.. (2015). JUSTICIA CONTRACTUAL Y LOS SERES DEL FUTURO. 3 indexed citations
2.
Hans, Daniel, Tiiu Ojasoo, & Jean‐Christophe Doré. (2000). Deaths from breast cancer: tackling multidimensionality and non-linearity by correspondence analysis. The Journal of Steroid Biochemistry and Molecular Biology. 74(4). 195–202. 2 indexed citations
3.
Eibl, Regine, et al.. (1999). Zellkulturtechnik : Einsatz eines Taumelreaktorsystems mit interner Beleuchtung. Zürcher Hochschule für Angewandte Wissenschaften digital collection (Zurich University of Applied Sciences). 2. 10–12. 1 indexed citations
4.
Amalric, R, et al.. (1998). Résultats du traitement par chirurgie conservatrice et irradiation de 132 carcinomes canalaires in situ non palpables du sein. Cancer/Radiothérapie. 2(1). 19–26. 3 indexed citations
5.
Brandone, H, Y Aymé, Daniel Hans, et al.. (1995). [Conservative treatment of sub-clinical noninfiltrating cancers of the breast (102 EOA in situ, TONO)].. PubMed. 49(1). 56–61. 2 indexed citations
6.
Viens, Patrice, Didier Blaise, A.-M. Stoppa, et al.. (1992). Interleukin-2 in Association with Increasing Doses of Interferon-Gamma in Patients with Advanced Cancer. Journal of Immunotherapy. 11(3). 218–224. 3 indexed citations
7.
Kurtz, John M., Jocelyne Jacquemier, R Amalric, et al.. (1991). Is breast conservation after local recurrence feasible?. European Journal of Cancer and Clinical Oncology. 27(3). 240–244. 86 indexed citations
8.
Jacquemier, Jocelyne, et al.. (1991). Inoperable recurrence after breast-conserving surgical treatment and radiotherapy.. PubMed. 172(5). 357–61. 21 indexed citations
9.
Romain, S, F. Spyratos, Y Aymé, et al.. (1991). [Reevaluation of indications for adjuvant hormone therapy in primary breast cancer with high metastatic risk].. PubMed. 78(8). 709–23. 3 indexed citations
10.
Kurtz, Julia, Jocelyne Jacquemier, R. Amalric, et al.. (1990). Why are local recurrences after breast-conserving therapy more frequent in younger patients?. Journal of Clinical Oncology. 8(4). 591–598. 205 indexed citations
11.
Kurtz, John M., J M Spitalier, R. Amalric, et al.. (1990). The prognostic significance of late local recurrence after breast-conserving therapy. International Journal of Radiation Oncology*Biology*Physics. 18(1). 87–93. 145 indexed citations
12.
Kurtz, John M., Jocelyne Jacquemier, R. Amalric, et al.. (1990). Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer. 65(8). 1867–1878. 157 indexed citations
13.
Jacquemier, Jocelyne, et al.. (1990). Breast-conserving Therapy for Macroscopically Multiple Cancers. Annals of Surgery. 212(1). 38–44. 156 indexed citations
14.
Kurtz, John M., R. Amalric, H Brandone, et al.. (1989). Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer. 63(10). 1912–1917. 341 indexed citations
15.
Kurtz, Julia, J M Spitalier, R Amalric, et al.. (1989). Time Course and Prognosis of Mammary Failure Following Breast-Conserving Therapy. Recent results in cancer research. 115. 77–82. 1 indexed citations
16.
Kurtz, John M., J M Spitalier, R. Amalric, et al.. (1988). Mammary recurrences in women younger than forty. International Journal of Radiation Oncology*Biology*Physics. 15(2). 271–276. 102 indexed citations
17.
Spitalier, J M, H Brandone, Y Aymé, et al.. (1986). Breast‐conserving surgery with radiation therapy for operable mammary carcinoma: A 25‐year experience. World Journal of Surgery. 10(6). 1014–1019. 45 indexed citations
18.
Treut, Y. P. Le, et al.. (1985). [Cancer of the gastric antrum. What can be expected from the systematic enlargement of the excision? Retrospective study of 73 cases].. PubMed. 14(24). 1319–22, 1327. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026